Cyst fluid study for disease markers
Part of Bones, joints & muscles, Cancer, Mouth & dental clinical trials.
This trial looks at fluid from cysts to find markers that might show disease. If you have a cyst and are not pregnant or breastfeeding, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a cyst.
- You are not pregnant or breastfeeding.
- You agree to sign a consent form.
- You are healthy enough for surgery (if needed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at certain substances in the fluid around the lungs (pleural effusion) of people with lung adenocarcinoma. It may help doctors understand this condition better and find new ways to treat it.
This study looks for “biomarkers,” or measurable lab signals, in blood and (when available) cyst fluid to understand pancreatic cyst problems and related conditions. It may help doctors better predict what these conditions are and how to manage them.
This trial collects pancreatic cyst fluid or tissue to study the genes of these tumors. The goal is to better understand pancreatic cysts and improve future treatments.
This study collects blood and cystic fluid samples from people who are already scheduled for surgery to remove a worrisome pancreatic cyst. The goal is to learn more about these cysts and possibly improve future diagnosis and treatment.
This study looks for simple signals (markers) that may show whether cystic fibrosis treatments are working. It includes people who take CF “modulator” medicines like ivacaftor, people who don’t, and people whose cystic fibrosis was ruled out after testing.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
Hear when a new Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.